北米のデジタル病理市場規模、シェア、動向分析レポート：用途別、製品別、最終用途別、国別、セグメント予測、2025年～2030年

北米のデジタル病理市場の成長と動向

北米のデジタル病理市場規模は、2030年には6億9,390万米ドルに達し、2025～2030年にかけてCAGR 7.8%で成長すると予測されます。

同市場は、がんなどの慢性疾患の有病率の増加が主要要因となっています。がんの罹患率が高い結果、病理医は患者の個別化治療を促進するデータを必要としています。したがって、デジタル病理は、診断速度の加速、診断の正確さ、患者の転帰を改善するための治療勧告の提供など、さまざまな利点があるため、病理医によって徐々に選択されています。

がん診断におけるデジタル病理の採用を促進するだけでなく、開発するための共同契約の数が増加していることも、市場に寄与する主要な成長要因となっています。デジタル病理診断における人工知能の利用は、ここ数年で勢いを増しています。医療コストの削減ニーズの高まり、医療におけるビッグデータの重要性の高まり、精密医療の採用の高まり、ハードウェアコストの低下などが成長を促進する要因となっています。さらに、医療における人工知能ベースの分析ツールの利用増加や、このセグメントへの高い設備投資が、市場の成長をさらに後押ししています。

コロナウイルスの大流行時には、医療従事者が遠隔で画像を読み取り、多職種のケアチーム間の仮想コラボレーションを可能にする在宅ワークステーションや安全な臨床情報システムのニーズが急増しました。この地域の様々な病理組織科は、パンデミックの間、労働力の減少と仕事量の増加に直面しました。デジタル病理は、病理医が直面するいくつかの課題の潜在的な解決策であると考えられ、コロナウイルスの流行時に疾患のデジタル診断の採用が増加しています。

2020年4月、PhilipsはFDAが緊急時に同社のIntelliSite Pathology Solutionを搭載したコンシューマーモニターの家庭での使用を免除したと発表しました。デジタル病理の遠隔使用に関する制限の一時的免除は、病理医が自宅から全スライド画像にアクセスし、組織診断症例の診断を迅速化するのに役立ちます。COVID-19以前に、異なる施設間のワークフローにDPを採用した病理検査室では、共同作業が改善され、平均生産性が21.0%向上し、作業効率が13.0%向上したと報告しているところもあります。このような取り組みが市場成長を促進すると予想されます。

北米のデジタル病理市場レポートハイライト

• 北米のデジタル病理市場は現在、加速度的に大きな成長を遂げています。
• 2024年にはデバイスセグメントが52.07%の最大シェアを占めました。
• 人間病理学セグメントは2024年に最大のシェアを占めました。
• 2024年の予測期間では、学術研究セグメントが市場を独占しました。
• 米国のデジタル病理市場は、2024年に地域別市場で最大のシェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場系統の展望
  • 親市場分析
  • 補助市場分析
• 北米のデジタル病理市場-市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場課題分析
• 北米のデジタル病理市場分析ツール：ポーターのファイブフォース分析
  • サプライヤーの交渉力
  • 買い手の交渉力
  • 代替の脅威
  • 新規参入者からの脅威
  • 競争企業間の敵対関係
• PESTLE分析
  • 政治
  • 経済と社会
  • 技術
  • 環境
  • 法的
• 使用事例と洞察
• COVID-19の影響

第4章 北米のデジタル病理市場：製品別、推定・動向分析

• 北米のデジタル病理市場、製品別：主要ポイント
• 北米のデジタル病理市場：製品動向と市場シェア分析、2024年と2030年
• ソフトウェア
• デバイス
  • スキャナー
  • スライド管理システム
• ストレージシステム

第5章 北米のデジタル病理市場：タイプ別、推定・動向分析

• 北米のデジタル病理市場、タイプ別：主要ポイント
• 北米のデジタル病理市場：タイプ動向と市場シェア分析、2024年と2030年
• 動物病理学
• 人間病理学

第6章 北米のデジタル病理市場：用途別、推定・動向分析

• 北米のデジタル病理市場、用途別：主要ポイント
• 北米のデジタル病理市場：用途動向と市場シェア分析、2024年と2030年
• 医薬品の発見と開発
• 学術研究
• 病気の診断
  • がん細胞の検出
  • その他

第7章 北米のデジタル病理市場：最終用途別、推定・動向分析

• 北米のデジタル病理市場、最終用途別：主要ポイント
• 北米のデジタル病理市場：最終用途動向と市場シェア分析、2024年と2030年
• 病院
• バイオテクノロジーと製薬企業
• 診断ラボ
• 学術研究機関

第8章 北米のデジタル病理市場：国別、推定・動向分析

• 北米のデジタル病理市場：地域変動分析、2024年と2030年
• 地域別市場ダッシュボード
• 地域市場のスナップショット
  • 北米

第9章 競合情勢

• 企業分類
• 競合市場への参入戦略
• 非公開会社/ベンダー（国/地域別）
• 企業の市場シェア/ポジション分析、2024年
• 企業プロファイル/上場企業
  • Leica Biosystems Nussloch GmbH（Danaher）
  • Hamamatsu Photonics, Inc
  • Koninklijke Philips NV
  • Olympus Corporation
  • F. Hoffmann-La Roche Ltd
  • Mikroscan Technologies, Inc
  • Inspirata, Inc.
  • Epredia（3DHISTECH Ltd.）
  • Huron Technologies International Inc.
  • CellaVision
  • Morphle Labs, Inc
  • Bionovation BIoTech, Inc

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 North America Digital Pathology Market, By Region, 2018 - 2030 (USD Million)
• Table 4 North America Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
• Table 5 North America Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
• Table 6 North America Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
• Table 7 North America Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
• Table 8 North America Digital Pathology Market, By Country, 2018 - 2030 (USD Million)
• Table 9 North America Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
• Table 10 North America Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
• Table 11 North America Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
• Table 12 North America Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
• Table 13 U.S. Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
• Table 14 U.S. Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
• Table 15 U.S. Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
• Table 16 U.S. Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
• Table 17 Canada Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
• Table 18 Canada Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
• Table 19 Canada Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
• Table 20 Canada Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)
• Table 21 Mexico Digital Pathology Market, By Product, 2018 - 2030 (USD Million)
• Table 22 Mexico Digital Pathology Market, By Type, 2018 - 2030 (USD Million)
• Table 23 Mexico Digital Pathology Market, By Application, 2018 - 2030 (USD Million)
• Table 24 Mexico Digital Pathology Market, By End-Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 North America Digital pathology market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2024)
• Fig. 10 Strategy framework
• Fig. 11 Market driver relevance analysis (Current & future impact)
• Fig. 12 Market restraint relevance analysis (Current & future impact)
• Fig. 13 Penetration & growth prospect mapping
• Fig. 14 Porter's five forces analysis
• Fig. 15 PESTLE analysis
• Fig. 16 North America Digital pathology market: Product movement analysis
• Fig. 17 North America Digital pathology market: Product segment dashboard
• Fig. 18 North America Digital pathology market product outlook: Key takeaways
• Fig. 19 Software market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Integrated Software market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Standalone Software market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Device market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Storage system market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 North America Digital pathology market: Type movement analysis
• Fig. 25 North America Digital pathology market: Type segment dashboard
• Fig. 26 North America Digital pathology market type outlook: Key takeaways
• Fig. 27 Human digital pathology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Veterinary digital pathology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 North America Digital pathology market: Application movement analysis
• Fig. 30 North America Digital pathology market: Application segment dashboard
• Fig. 31 North America Digital pathology market application outlook: Key takeaways
• Fig. 32 North America Drug discovery & development market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Academic research market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Disease diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 North America Digital pathology market: End-use movement analysis
• Fig. 36 North America Digital pathology market: End-use segment dashboard
• Fig. 37 North America Digital pathology market end-use outlook: Key takeaways
• Fig. 38 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 Biotech & pharma companies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 40 Diagnostic labs market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 41 Academic &research institutes market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 42 Regional outlook, 2024 & 2030
• Fig. 43 Regional market dashboard
• Fig. 44 Regional market place: Key takeaways
• Fig. 45 North America, SWOT
• Fig. 46 North America Digital pathology market, 2018 - 2030 (USD Million)
• Fig. 47 U.S. Digital pathology market, 2018 - 2030 (USD Million)
• Fig. 48 Canada Digital pathology market, 2018 - 2030 (USD Million)
• Fig. 49 Mexico Digital pathology market, 2018 - 2030 (USD Million)

North America Digital Pathology Market Growth & Trends:

The North America digital pathology market size is expected to reach USD 693.9 million in 2030 and is expected to grow at a CAGR of 7.8% from 2025 to 2030. The market is predominantly driven by the growing prevalence of chronic diseases such as cancer. As a consequence of the high prevalence of cancer, pathologists require data that facilitate personalizing therapy for patients. Hence, digital pathology is progressively being selected by pathologists as it has various benefits including accelerated diagnosis rate, diagnostic accuracy, and offers therapeutic recommendations to improve patient outcomes.

The growing number of collaborative agreements to develop as well as expedite the adoption of digital pathology in cancer diagnostics serves as a key growth factor contributing to the market. The use of artificial intelligence in digital pathology has gained momentum in the past years. The increasing need for lowering healthcare costs, increasing importance of big data in healthcare, rising adoption of precision medicine, and declining hardware costs are some factors driving the growth. In addition, increasing usage of artificial intelligence-based analytical tools in healthcare and high capital investments in this field are further propelling the market growth.

During the coronavirus outbreak, the exponential need for home-based workstations and safe clinical informatics systems allowing healthcare professionals to read images remotely and enabling virtual collaboration between their multi-disciplinary care teams has increased. Various histopathology departments in the region faced a reducing workforce and increasing workload during the pandemic. Digital pathology considered being the potential solution for some of the challenges faced by the pathologist, there is an increase in the adoption of digital diagnosis of disease during coronavirus outbreak.

In April 2020, Philips announced that the FDA granted a waiver for home use of consumer monitors with the company's IntelliSite Pathology Solution during the emergency. The temporary exemption of restrictions on remote use of the digital pathology helps pathologists to access whole slide images from home and fasten the diagnosis of histology cases. Some pathology labs that have adopted DP in their workflows across different sites pre-COVID-19, reported improved collaboration, and an average productivity gain of 21.0% with operation efficiency increased by 13.0%. These types of initiatives are anticipated to fuel market growth.

North America Digital Pathology Market Report Highlights:

• North America digital pathology market is currently experiencing significant growth, at an accelerating pace
• The device segment held the largest share of 52.07% in 2024
• The human pathology segment held the largest share in 2024
• The academic research segment dominated the market in 2024he forecast period
• The digital pathology market in the U.S. dominated the regional market with the largest share in 2024

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database:
  • 1.3.2. Gvr's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research:
  • 1.3.5. Details Of Primary Research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for Primary Interviews in Europe
    • 1.3.5.3. Data for Primary Interviews in APAC
    • 1.3.5.4. Data for Primary Interviews in Latin America
    • 1.3.5.5. Data for Primary Interviews in MEA
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity Flow Analysis
  • 1.6.2. Top Down Market Estimation
  • 1.6.3. CAGR Calculation
  • 1.6.4. Key Report Updates
• 1.7. List of Secondary Sources
• 1.8. List of Abbreviations
• 1.9. Report Objectives
  • 1.9.1. Objective - 1
  • 1.9.2. Objective - 2

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segmental Snapshot
• 2.3. Competitive Insights Snapshot

Chapter 3. Market Variables, Trends, and Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Analysis
  • 3.1.2. Ancillary Market Analysis
• 3.2. North America Digital Pathology Market- Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of chronic diseases
    • 3.2.1.2. Higher cost-efficiency
    • 3.2.1.3. Rapid technological advancements in the overall digital pathology market
      • 3.2.1.3.1. Competitive Factors and Strategies
      • 3.2.1.3.2. List of Top Notable Funded Digital Pathology Companies
      • 3.2.1.3.3. Top 10 Vendor - by Total Funding from 2014 - 2021 (Potential vendors for collabrations)
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of skilled professionals
    • 3.2.2.2. High cost of implementing digital pathology solutions
  • 3.2.3. Market Challenges Analysis
• 3.3. North America Digital Pathology Market Analysis Tools: Porters Five Forces
  • 3.3.1. Bargaining power of the suppliers
  • 3.3.2. Bargaining power of the buyers
  • 3.3.3. Threats of substitution
  • 3.3.4. Threats from new entrants
  • 3.3.5. Competitive rivalry
• 3.4. PESTLE Analysis
  • 3.4.1. Political landscape
  • 3.4.2. Economic and Social landscape
  • 3.4.3. Technological landscape
  • 3.4.4. Environmental landscape
  • 3.4.5. Legal landscape
• 3.5. Case Studies & Inisghts
• 3.6. Impact of COVID 19

Chapter 4. North America Digital Pathology Market: Product Estimates & Trend Analysis

• 4.1. North America Digital Pathology Market, Product Type: Key Takeaways
• 4.2. North America Digital Pathology Market: Product Type Movement & Market Share Analysis, 2024 & 2030
• 4.3. Software
  • 4.3.1. Software Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
• 4.4. Devices
  • 4.4.1. Devices Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 4.4.2. Scanners
    • 4.4.2.1. Scanners market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.4.3. Slide Management System
    • 4.4.3.1. Slide management system market estimates and forecast, 2018 - 2030 (USD Million)
• 4.5. Storage Systems
  • 4.5.1. Storage Systems Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. North America Digital Pathology Market: Type Estimates & Trend Analysis

• 5.1. North America Digital Pathology Market, by Type: Key Takeaways
• 5.2. North America Digital Pathology Market: Type Movement & Market Share Analysis, 2024 & 2030
• 5.3. Veterinary Pathology
  • 5.3.1. Veterinary Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
• 5.4. Human Pathology
  • 5.4.1. Human Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. North America Digital Pathology Market: Application Estimates & Trend Analysis

• 6.1. North America Digital Pathology Market, Application Type: Key Takeaways
• 6.2. North America Digital Pathology Market: Application Movement & Market Share Analysis, 2024 & 2030
• 6.3. Drug Discovery & Development
  • 6.3.1. Drug Discovery & Development Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
• 6.4. Academic Research
  • 6.4.1. Academic Research Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
• 6.5. Disease Diagnosis
  • 6.5.1. Disease Diagnosis Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.5.2. Cancer Cell Detection
    • 6.5.2.1. Cancer Cell Detection Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.5.3. Others
    • 6.5.3.1. Others Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. North America Digital Pathology Market: End Use Estimates & Trend Analysis

• 7.1. North America Digital Pathology Market, By End Use: Key Takeaways
• 7.2. North America Digital Pathology Market: End Use Movement & Market Share Analysis, 2024 & 2030
• 7.3. Hospitals
  • 7.3.1. Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.4. Biotech & Pharma Companies
  • 7.4.1. Biotech & Pharma Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.5. Diagnostics Labs
  • 7.5.1. Diagnostics Labs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.6. Academic & Research Institutes
  • 7.6.1. Academic & Research Institutes Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. North America Digital Pathology Market: Country Estimates & Trend Analysis

• 8.1 North America Digital Pathology Market: Regional Movement Analysis, 2024 & 2030
• 8.2 Regional Market Dashboard
• 8.3 Regional Market Snapshot
  • 8.3.1 North America
    • 8.3.1.1 North America Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.1.2 U.S.
      • 8.3.1.2.1 Key Country Dynamics
      • 8.3.1.2.2 Competitive Scenario
      • 8.3.1.2.3 Regulatory Framework
      • 8.3.1.2.4 Reimbursement Scenario
      • 8.3.1.2.5 U.S. Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.1.3 Canada
      • 8.3.1.3.1 Key Country Dynamics
      • 8.3.1.3.2 Competitive Scenario
      • 8.3.1.3.3 Regulatory Framework
      • 8.3.1.3.4 Reimbursement Scenario
      • 8.3.1.3.5 Canada Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.1.4 Mexico
      • 8.3.1.4.1 Key Country Dynamics
      • 8.3.1.4.2 Competitive Scenario
      • 8.3.1.4.3 Regulatory Framework
      • 8.3.1.4.4 Reimbursement Scenario
      • 8.3.1.4.5 Mexico Digital Pathology Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Competitive Market Entry Strategies
• 9.3. Private Companies/ Vendors, By Country/Region
• 9.4. Company Market Share/Position Analysis, 2024
• 9.5. Company Profiles/Listing
  • 9.5.1. Leica Biosystems Nussloch GmbH (Danaher)
    • 9.5.1.1. Overview
    • 9.5.1.2. Financial Performance
    • 9.5.1.3. Product Benchmarking
    • 9.5.1.4. Strategic Initiatives
  • 9.5.2. Hamamatsu Photonics, Inc
    • 9.5.2.1. Overview
    • 9.5.2.2. Financial Performance
    • 9.5.2.3. Product Benchmarking
    • 9.5.2.4. Strategic Initiatives
  • 9.5.3. Koninklijke Philips N.V.
    • 9.5.3.1. Overview
    • 9.5.3.2. Financial Performance
    • 9.5.3.3. Product Benchmarking
    • 9.5.3.4. Strategic Initiatives
  • 9.5.4. Olympus Corporation
    • 9.5.4.1. Overview
    • 9.5.4.2. Financial Performance
    • 9.5.4.3. Product Benchmarking
    • 9.5.4.4. Strategic Initiatives
  • 9.5.5. F. Hoffmann-La Roche Ltd
    • 9.5.5.1. Overview
    • 9.5.5.2. Financial Performance
    • 9.5.5.3. Product Benchmarking
    • 9.5.5.4. Strategic Initiatives
  • 9.5.6. Mikroscan Technologies, Inc
    • 9.5.6.1. Overview
    • 9.5.6.2. Financial Performance
    • 9.5.6.3. Product Benchmarking
    • 9.5.6.4. Strategic Initiatives
  • 9.5.7. Inspirata, Inc.
    • 9.5.7.1. Overview
    • 9.5.7.2. Financial Performance
    • 9.5.7.3. Product Benchmarking
    • 9.5.7.4. Strategic Initiatives
  • 9.5.8. Epredia (3DHISTECH Ltd.)
    • 9.5.8.1. Overview
    • 9.5.8.2. Financial Performance
    • 9.5.8.3. Product Benchmarking
    • 9.5.8.4. Strategic Initiatives
  • 9.5.9. Huron Technologies International Inc.
    • 9.5.9.1. Overview
    • 9.5.9.2. Financial Performance
    • 9.5.9.3. Product Benchmarking
    • 9.5.9.4. Strategic Initiatives
  • 9.5.10. CellaVision
    • 9.5.10.1. Overview
    • 9.5.10.2. Financial Performance
    • 9.5.10.3. Product Benchmarking
    • 9.5.10.4. Strategic Initiatives
  • 9.5.11. Morphle Labs, Inc
    • 9.5.11.1. Overview
    • 9.5.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.5.11.3. Product Benchmarking
    • 9.5.11.4. Strategic Initiatives
  • 9.5.12. Bionovation Biotech, Inc
    • 9.5.12.1. Overview
    • 9.5.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.5.12.3. Product Benchmarking
    • 9.5.12.4. Strategic Initiatives